stockrow
Saturday 7 November 2026
Export BMEA’s income statement to Excel — free account
Biomea Fusion, Inc.
BMEA Healthcare Biotechnology
- EPS
- +76.5%
- Free cash flow
- +47.8%
Quarter to June 2026, against a year earlier
0.56
0.03
−5.08%
Follow BMEA
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.48 | 4.98 | 5.23 | 3.18 |
+8 more quarters Free account |
Net Debt/EBITDA |
2.76 | 3.54 | 4.78 | 2.29 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.20 | 0.94 | (3.02) | 0.70 | |
Capex/Depreciation |
0.00 | 11.96 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.14) | (0.15) | (0.19) | (0.19) | |
Cash per Share |
0.49 | 0.62 | 0.78 | 0.78 | |
Shareholders Equity per Share |
0.17 | 0.26 | 0.41 | 0.26 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.17 | 0.26 | 0.41 | 0.26 | |
Free Cash Flow |
(10.03) | (11.12) | (13.94) | (11.55) | |
Working Capital |
25.95 | 37.02 | 46.95 | 33.88 | |
Capital Expenditures |
0.00 | 0.55 | — | — | |
Net Current Asset Value |
11.69 | 18.65 | 29.03 | 9.87 | |
| Other line items | |||||
Quick Ratio |
3.36 | 4.85 | 5.03 | 3.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.14) | (0.16) | (0.19) | (0.19) | |
Capex per Share |
0.00 | 0.01 | 0.00 | 0.00 | |
Average Payables |
5.84 | 6.16 | 8.08 | 7.69 | |
Average Assets |
55.02 | 50.72 | 69.26 | 82.80 | |
Average Common Equity |
19.82 | 23.73 | 40.56 | 45.80 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates · fundamentals updated 26 Oct 2026